Search Results - Preisack, Melitta B.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)

    Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, mul... by Karsch, Karl R., Preisack, Melitta B., Baildon, Rainer, Eschenfelder, Volker, Foley, David, Garcia, Eulogio J., Kaltenbach, Martin, Meisner, Christoph, Selbmann, Hans K., Serruys, Patrick W., Shiu, Man F., Sujatta, Martin, Bonan, Raoul

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty : A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial)

    Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty : A comparison between treatment with reviparin and unfractionat... by PREISACK, M. B, BONAN, R, MEISNER, C, ESCHENFELDER, V, KARSCH, K. R

    Published in European heart journal
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Low molecular weight heparin, reviparin, in prevention of restenosis after PTCA: Results of the REDUCE trial

    Low molecular weight heparin, reviparin, in prevention of restenosis after PTCA: Results of the REDUCE trial by Karsch, Karl R., Preisack, Melitta B., Bonan, Raoul

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Comparison between unfractionated heparin and low molecular weight heparin during percutaneous transluminal coronary angioplasty in the 24 hours after intervention

    Comparison between unfractionated heparin and low molecular weight heparin during percutaneous transluminal coronary angioplasty in the 24 hours after intervention by Bonan, Raoul, Preisack, Melitta B., Karsch, Karl R.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Low molecular weight heparin in prevention of restenosis after PTCA

    Low molecular weight heparin in prevention of restenosis after PTCA by Preisack, Melitta B., Karsch, Karl R.

    Published in Thrombosis research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Reliability of quantitative coronary angiography of the target lesion immediately and 1 day after coronary balloon and excimer laser angioplasty

    Reliability of quantitative coronary angiography of the target lesion immediately and 1 day after coronary balloon and excimer laser angioplasty by Preisack, Melitta B., Athanasiadis, Anastasios, Voelker, Wolfram, Karsch, Karl R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: